What will AI mean for humanity? bcbn.org/boston-cambrid… #news #biotech

Alnylam receives subpoena from US Attorney’s Office amid strong Q3 earnings bcbn.org/boston-cambrid… #news #biotech

Guardian Angel Senior Services Expands, Continues Workforce Training Scholarship Program in New Hampshire bcbn.org/boston-cambrid… #news #biotech

Biogen boosts sales outlook on ‘resilient’ legacy MS franchise as new launches build momentum bcbn.org/boston-cambrid… #news #biotech

Gut Neurons Decoded: New Study Reveals How Food Allergies and Microbes Rewire Gut Neuronal Responses bcbn.org/boston-cambrid… #news #biotech

BridgeBio’s great week and Moderna’s unraveling bcbn.org/boston-cambrid… #news #biotech

Q&A: How MITHIC is fostering a culture of collaboration at MIT bcbn.org/boston-cambrid… #news #biotech

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 bcbn.org/boston-cambrid… #news #biotech

Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates bcbn.org/boston-cambrid… #news #biotech

Corbus Pharmaceuticals Announces Proposed Public Offering bcbn.org/boston-cambrid… #news #biotech

How NEB’s Customized Solutions Team Drives Innovation and Partnership in Biotech bcbn.org/boston-cambrid… #biotech #news

Corbus Pharmaceuticals Announces Pricing of Public Offering bcbn.org/boston-cambrid… #news #biotech

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth bcbn.org/boston-cambrid… #news #biotech

Guardian Angel Senior Services Adds 13th Massachusetts Location bcbn.org/boston-cambrid… #biotech #news

New nanoparticles stimulate the immune system to attack ovarian tumors bcbn.org/boston-cambrid… #news #biotech

Mass. insurers take a tougher stand against healthcare providers bcbn.org/boston-cambrid… #news #biotech

T1D Fund seeks to raise $150M with focus on bigger biotech investments bcbn.org/boston-cambrid… #biotech #news

Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy bcbn.org/boston-cambrid… #news #biotech

Judges order the Trump administration to use contingency funds for SNAP payments during the shutdown bcbn.org/boston-cambrid… #biotech #news

AI Models Enhance the Drug Discovery Portfolio bcbn.org/boston-cambrid… #biotech #news